Prematurity can alter nearly every stage of host defence. Infants born before term may have lower concentrations of maternally transferred immunoglobulin G, because a substantial proportion of placental antibody transfer occurs late in pregnancy. Their skin and mucosal surfaces are also less mature, while their respiratory systems are more susceptible to inflammation and impaired clearance of pathogens. In addition, many preterm infants require prolonged hospital care, respiratory support or repeated medical procedures, all of which can increase opportunities for exposure to infectious agents. Viral illnesses that are relatively mild in older children can therefore cause bronchiolitis, pneumonia, feeding difficulty, dehydration or prolonged hospitalisation in infants born prematurely.

Breast milk contains more than calories, proteins and fats. It is a complex biological fluid carrying antibodies, immune cells, cytokines, oligosaccharides, antimicrobial proteins and molecules that help regulate inflammation. Secretory immunoglobulin A, or sIgA, is particularly important at mucosal surfaces. Rather than circulating primarily through the bloodstream, sIgA can bind pathogens in the mouth, throat and gastrointestinal tract, limiting their attachment to epithelial cells and reducing the likelihood that viruses will cross the mucosal barrier. Human milk oligosaccharides can also act as decoys for microbes and support beneficial bacterial communities in the intestine, potentially influencing the development of systemic and mucosal immunity.

The study’s central exposure is breastfeeding status up to six months of age, a period that includes major changes in infant feeding and immune maturation. In a cohort design, researchers follow a defined group of infants over time and compare health outcomes according to an exposure measured during the study period. Here, the outcome of interest is the incidence of viral infections during the first year of life. This approach is useful because it can capture infections as they occur rather than relying entirely on parental recall after the fact. It may also allow investigators to examine whether an association persists beyond the immediate neonatal period, when breastfeeding and hospital-based care are closely intertwined.

The relationship between breastfeeding and infection is biologically plausible but scientifically difficult to interpret. Infants who receive breast milk may differ from those who do not in many ways unrelated to milk itself. Maternal health, socioeconomic conditions, access to lactation support, mode of delivery, household crowding, exposure to siblings, vaccination, smoking exposure and the severity of the infant’s prematurity can all affect infection risk. The need for neonatal intensive care may influence both the ability to breastfeed and the likelihood of encountering respiratory viruses. For this reason, a multicenter cohort can be valuable: data collected across different hospitals and clinical settings may provide a broader picture than a single-unit study, although observational research cannot by itself prove that breastfeeding directly prevents infection.

The investigators’ focus on viral infections is especially relevant because viruses remain a major cause of respiratory and gastrointestinal illness in the first year of life. Respiratory syncytial virus, influenza, rhinoviruses, adenoviruses, human metapneumovirus and other respiratory pathogens can be consequential for preterm infants, whose smaller airways and limited pulmonary reserve may magnify the effects of inflammation and mucus production. Gastrointestinal viruses can be equally disruptive, particularly when vomiting or diarrhoea compromises hydration and nutritional recovery. The biological effects of breast milk may differ according to the virus, the route of exposure and whether protection occurs through direct neutralisation, altered microbial ecology or modulation of the infant’s inflammatory response.

A key scientific issue is how breastfeeding status is defined. “Breastfeeding” can refer to exclusive breastfeeding, predominant breastfeeding, any breast milk intake or a combination of breast milk and formula. These categories may have different biological implications. The volume and duration of milk exposure may also matter, as may whether the infant receives fresh milk, expressed milk or donor milk. For preterm infants, feeding is often interrupted by medical instability, and some infants transition gradually from tube feeding to oral feeding. A careful analysis therefore needs to distinguish the timing and continuity of breast-milk exposure from the broader clinical circumstances surrounding birth and hospital discharge. The study’s stated six-month window highlights the importance of these details in evaluating longer-term associations.

The findings from this research may help clinicians refine infection-prevention counselling for families of preterm infants, but they should be interpreted within the limits of the evidence reported. The available study description identifies the objective and design but does not provide numerical results, infection-specific estimates or conclusions about causality. It therefore cannot support a claim that breastfeeding eliminates viral infections or that every preterm infant who receives breast milk will experience fewer illnesses. Breastfeeding support must remain individualised, respectful and medically appropriate, particularly when mothers face illness, medication use, low milk production, psychological stress or barriers to expressing milk. When direct breastfeeding is not possible, expressed maternal milk may still provide many of the same biological components, while donor milk and specialised formulas may be clinically necessary alternatives.

By examining viral infections across the first year rather than only during the neonatal admission, the multicenter cohort study places breastfeeding within the broader timeline of infant immune development. Protection in early life is rarely determined by one factor. Maternal antibodies, vaccination, infection-control practices, ventilation, hand hygiene, household exposure and timely medical care all contribute to risk. Breast milk may form one layer in this defence system, supplying locally active antibodies and immune-regulating compounds during a period when the infant’s own responses are still being calibrated. The significance of the work lies in testing that possibility in preterm infants, a group for whom even modest reductions in viral illness could have meaningful consequences for respiratory health, growth and hospital use. Further studies, including analyses that clarify viral species, feeding intensity and potential confounding factors, will be needed to determine how strongly breastfeeding status predicts infection and which mechanisms are most important.

Subject of Research: Breastfeeding and viral infections in preterm infants

Article Title: Breastfeeding and viral infections in preterm infants: a multicenter cohort study

Article References: Kamiya, Y., Takeuchi, A., Nakamura, K. et al. Breastfeeding and viral infections in preterm infants: a multicenter cohort study. Pediatric Research (2026). https://doi.org/10.1038/s41390-026-05373-x

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05373-x

Keywords: breastfeeding, preterm infants, viral infections, infant immunity, human milk, respiratory infections, multicenter cohort study, neonatal health

The neonatal gut environment is a highly dynamic interface where the immune system encounters a diverse array of microbial and dietary antigens. This interaction is critical, as an inappropriate immune response during early life can predispose individuals to chronic inflammatory conditions. The study by Shenoy et al. demonstrates that maternally derived IgG antibodies, transferred through breastfeeding within the first postnatal week, selectively bind to intestinal bacteria in the neonatal gut. These antibody-bacteria complexes subsequently engage Fc gamma receptors on intestinal immune cells, orchestrating a finely tuned immune modulation that tempers T cell responsiveness.

This immunomodulatory mechanism ensures the prevention of excessive inflammation in response to food antigens during the vulnerable weaning period, thus promoting tolerance while maintaining robust defense capabilities against pathogens. Notably, the study also shows that this antibody-dependent pathway restricts immune overactivation in models of experimentally induced colitis during early life, highlighting its protective relevance in preventing inflammatory bowel diseases. This insight into IgG-mediated immune instruction underscores a critical window during which maternal antibodies sculpt the neonatal immune landscape.

The role of immunoglobulin G in this context contrasts with the previously well-characterized functions of secretory IgA in the gut, expanding our understanding of how different antibody classes contribute to immune homeostasis. While IgA is thought to primarily function by immune exclusion and neutralization of pathogens, maternal IgG appears to have a more instructive role, directly modulating immune cell responses to maintain tolerance and prevent inappropriate inflammation. This distinction underscores the complexity of antibody functions in early life immunity and suggests potential novel avenues for therapeutic interventions targeting neonatal and infant gut health.

Understanding the interaction between maternal antibodies and the developing neonatal immune system requires dissecting the temporal aspects of antibody exposure. The study emphasizes that the timing and presence of IgG in breast milk are crucial for effective immune education. Neonates that lack access to these maternal antibodies exhibit heightened immune reactivity, indicating the indispensable role of maternal IgG in calibrating neonatal immune responses during critical developmental windows. These findings prompt further inquiries into how variations in breastfeeding practices or maternal antibody levels may influence infant health outcomes.

Moreover, the interplay between maternal IgG and the gut microbiome is integral to establishing a mutualistic relationship between host and microbes. By regulating immune reactivity, maternal antibodies facilitate a stable microbial colonization that supports nutrient assimilation and metabolic functions essential for growth and development. This relationship frames the gut as a communicative hub where maternal immunity and microbial ecology converge to instruct host physiology. The intricate dialogue mediated by antibody-coated bacteria serves as a fundamental axis in the early life establishment of immune tolerance.

While this research was conducted in murine models, its implications for human neonatal immunity are profound. Translation to human infants will necessitate comprehensive studies that integrate data on the ontogeny of immune system components, microbiota development, and patterns of maternal antibody transfer. Understanding how these factors interplay in human infants could inform strategies to enhance immune education through maternal vaccination or supplementation, thereby improving disease resistance and reducing early-life inflammatory disorders.

The demonstration that antibody engagement with gut microbes modulates T cell activity during weaning also advances our knowledge of tolerance induction mechanisms. T cells reactive to dietary and microbial antigens must be restrained to prevent chronic inflammation, and maternal IgG appears to contribute to this restraint by signaling through gut mucosa antibody receptors. Such insights into the immune synapse between antibody-coated bacteria and immune cells open novel perspectives on manipulating immune responses in pediatric gastrointestinal diseases.

Interestingly, this model highlights not just passive immunity through antibody transfer but an active role for maternal antibodies in educating the immune system. This active instruction may reshape how neonatal immunity is conceptualized, emphasizing the cooperative nature of maternal-infant immune interactions beyond mere protection. The learned immune responses facilitated by maternal IgG could set lifelong immune trajectories, affecting susceptibility to allergies, autoimmunity, and infections.

In light of the global burden of inflammatory and autoimmune diseases, understanding the early life determinants of immune regulation is critical. The findings by Shenoy et al. suggest that interventions enhancing maternal antibody quality or delivery could mitigate the risk of immune-mediated pathologies. Moreover, the specific engagement of Fc gamma receptors in this pathway offers potential molecular targets for therapeutic modulation of immune responses.

Overall, this research marks a significant advance in neonatal immunology, uncovering a sophisticated mechanism by which maternal antibodies mold the immune environment of the newborn gut. The delicate balance achieved through this process ensures both immune tolerance and defense, setting the stage for healthy development. Future investigations will undoubtedly explore the nuances of this antibody-mediated immune education and its translation into clinical applications, including vaccination strategies and microbiota-based therapies.

As the neonatal period represents a critical window of opportunity, enhancing our understanding of the immune-microbiome crosstalk mediated by maternal IgG holds promise for improving infant health worldwide. This work underscores the power of maternal immunity not merely as a shield but as a dynamic educator, guiding the newborn’s immune system through its formative encounters with the microbial world.

Subject of Research: Maternal IgG antibodies in breast milk modulate neonatal gut immune responses to bacteria, influencing immune tolerance and inflammation in early life.

Article Title: Breast milk IgG engages the mouse neonatal immune system to instruct responses to gut antigens

News Publication Date: 14-Aug-2025

Web References: 10.1126/science.ado5294

Keywords: Neonatal immunity, maternal antibodies, immunoglobulin G, gut microbiome, mucosal immunity, T cell modulation, immune tolerance, early life immune education, breast milk, inflammatory bowel disease, immune-microbiome interaction